{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:52:32Z","timestamp":1790419952872,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":648,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20591144"],"award-info":[{"award-number":["20591144"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22591024"],"award-info":[{"award-number":["22591024"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.bbmt.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T11:48:27Z","timestamp":1365594507000},"page":"1026-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors"],"prefix":"10.1016","volume":"19","author":[{"given":"Makoto","family":"Hirokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iwato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiwa","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.04.004_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.hoc.2009.01.009","article-title":"Diagnosis and management of acquired pure red cell aplasia","volume":"23","author":"Sawada","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bbmt.2013.04.004_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","article-title":"Acquired pure red cell aplasia: Updated review of treatment","volume":"142","author":"Sawada","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","article-title":"Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group","volume":"92","author":"Sawada","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.04.004_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: A nationwide cohort study in Japan by the PRCA collaborative study group","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.04.004_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.12871","article-title":"Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: A nationwide cohort study in Japan for the PRCA Collaborative Study Group","volume":"93","author":"Fujishima","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.04.004_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.21354","article-title":"Acquired pure red cell aplasia associated with malignant lymphomas: A nationwide cohort study in Japan for the PRCA Collaborative Study Group","volume":"84","author":"Hirokawa","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib7","series-title":"Pure red cell aplasia","author":"Dessypris","year":"1988"},{"key":"10.1016\/j.bbmt.2013.04.004_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","article-title":"Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation","volume":"75","author":"Gmur","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.004_bib9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3324\/haematol.12933","article-title":"Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program","volume":"93","author":"Kimura","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.04.004_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2141.2001.02734.x","article-title":"Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: A single-centre experience","volume":"113","author":"Stussi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","article-title":"Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Stussi","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.08073.x","article-title":"The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation","volume":"149","author":"Wang","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib13","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.transproceed.2009.06.189","article-title":"Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation","volume":"41","author":"Ozkurt","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2013.04.004_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pbc.21025","article-title":"ABO incompatible stem cell transplantation in children does not influence outcome","volume":"49","author":"Helming","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2013.04.004_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1365-2141.2003.04128.x","article-title":"Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation","volume":"120","author":"Lee","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2141.2005.05364.x","article-title":"Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation","volume":"128","author":"Griffith","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1702121","article-title":"Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation","volume":"25","author":"Lee","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.004_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1532\/IJH97.03123","article-title":"Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia","volume":"79","author":"Fujiwara","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V96.3.1150","article-title":"Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect","volume":"96","author":"Mielcarek","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.004_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1703699","article-title":"Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease","volume":"30","author":"Yamaguchi","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib22","first-page":"335","article-title":"Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team","volume":"13","author":"Ohashi","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002770000275","article-title":"Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: A case report and literature review","volume":"80","author":"Yang","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.2004.00320.x","article-title":"Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion","volume":"73","author":"Verholen","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703668","article-title":"Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia","volume":"30","author":"Maschan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl","key":"10.1016\/j.bbmt.2013.04.004_bib26","first-page":"ECR33","article-title":"Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia","volume":"90","author":"Helbig","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.04.004_bib27","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood.V77.4.906.906","article-title":"Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin","volume":"77","author":"Heyll","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.004_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1701012","article-title":"Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin","volume":"20","author":"Santamaria","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib29","first-page":"471","article-title":"Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant","volume":"10","author":"Labar","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib30","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/ndt\/gfg364","article-title":"Removal of persisting isohaemagglutinins with Ig-Therasorb immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation","volume":"18","author":"Rabitsch","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/sj.bmt.1704264","article-title":"Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: Removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption","volume":"32","author":"Rabitsch","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1537-2995.2000.40050543.x","article-title":"Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: A major ABO mismatch means problems","volume":"40","author":"Worel","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.04.004_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajh.20932","article-title":"Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells","volume":"82","author":"Fang","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00277-008-0599-0","article-title":"Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation","volume":"88","author":"Fang","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.004_bib37","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A\u00a0simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.bbmt.2013.04.004_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.bmt.1705765","article-title":"Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: A single institute experience in Japan","volume":"40","author":"Tomonari","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bmt.1705031","article-title":"Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants","volume":"36","author":"Damodar","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.004_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.13356","article-title":"Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins","volume":"94","author":"Stussi","year":"2009","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:44:35Z","timestamp":1761057875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1083879113001493"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}